BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 31906842)

  • 1. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment and management of tinea capitis in children.
    Ali S; Graham TA; Forgie SE
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea capitis: epidemiology, diagnosis and management strategies.
    Pomeranz AJ; Sabnis SS
    Paediatr Drugs; 2002; 4(12):779-83. PubMed ID: 12431130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.
    Chen X; Jiang X; Yang M; Bennett C; González U; Lin X; Hua X; Xue S; Zhang M
    J Am Acad Dermatol; 2017 Feb; 76(2):368-374. PubMed ID: 27816294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory tinea capitis: non-healing plaque on the occiput of a 4-year-old child.
    Ang CC; Tay YK
    Ann Acad Med Singap; 2010 May; 39(5):412-4. PubMed ID: 20535434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in the treatment of tinea capitis.
    Chan YC; Friedlander SF
    Expert Opin Pharmacother; 2004 Feb; 5(2):219-27. PubMed ID: 14996619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of tinea capitis in children.
    Kakourou T; Uksal U;
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tinea capitis: beyond griseofulvin.
    Elewski BE
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S27-30. PubMed ID: 10367913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Review of Tinea Capitis in Adults: Epidemiology, Risk Factors, Clinical Presentations, and Management.
    Hill RC; Gold JAW; Lipner SR
    J Fungi (Basel); 2024 May; 10(5):. PubMed ID: 38786712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.